Case Report: Cytomegalovirus Encephalitis in an HIV-Seropositive Person

Article

Case Report: Cytomegalovirus Encephalitis in an HIV-Seropositive Person

Cytomegalovirus (CMV) infection is common in persons with HIV/AIDS. It can affect the eye, lung, liver, GI tract, and nervous system. It is also a common cause of blindness in persons infected with HIV. We report a case of CMV encephalitis in a person in whom AIDS was recently diagnosed who did not have CMV retinitis on ophthalmological examination.

Recent Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Related Content
GLP-1 Mimetic Benefits Are Broad, Study Finds, But Risks Can't be Ignored / image credit Courtesy of Washington University School of Medicine

GLP-1 Mimetic Benefits Are Broad, New Study Finds, But Risks Can't Be Ignored

Grace Halsey
January 21st 2025
Article

Incretin-mimetics may have even broader application against disease than scientists can predict, but the risks are real, too, according to a study of 2 million.

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Keith A. Reynolds
October 1st 2024
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

Sen-Jam Pharmaceutical Reports Preliminary Phase 2 Results for SJP-002C in COVID-19 Treatment / Image credit: ©Mauro Rodrigues/AdobeStock

Sen-Jam Pharmaceutical Reports Preliminary Phase 2 Results for SJP-002C in COVID-19 Treatment

Sydney Jennings
January 20th 2025
Article

The novel therapeutic demonstrated a strong safety profile and showed efficacy in reducing symptoms during the early stages of treatment.

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Sydney Jennings
August 30th 2023
Podcast

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

GLP-1/GIP Dual Agonist HRS9531 Shows Promising Phase 2 Data for Obesity Management / image credit ©brovarky/stock.adobe.com

GLP-1/GIP Dual Agonist HRS9531 Shows Promising Phase 2 Data for Obesity Management

Grace Halsey
January 15th 2025
Article

More than half of study participants receiving the dual incretin agonist had weight loss of 20% or greater, with no evidence of a plateau and only mild AEs.

FDA Updates RSV Vaccine Labels to Include Guillain-Barré Syndrome Warning / Image credit: ©MargJohnsonVA/AdobeStock

FDA Updates RSV Vaccine Labels to Include Guillain-Barré Syndrome Warning

Sydney Jennings
January 8th 2025
Article

The FDA approved the addition of Guillain-Barré syndrome warnings for Abrysvo and Arexvy, citing postmarketing data suggesting an increased risk.

© 2025 MJH Life Sciences

All rights reserved.